OPTIMIZE-2: Study Evaluating the Efficacy and Safety of OCS-01 Eye Drops in Subjects Following Cataract Surgery (clinicaltrials.gov) - Jan 11, 2024 - P3 | N=160 | Recruiting | Sponsor: Oculis | Not yet recruiting ➔ Recruiting
Enrollment open • Surgery • Trial completion date • Trial initiation date • Trial primary completion date • Cataract • Inflammation • Ocular Inflammation • Ophthalmology • Pain
|